International Patent: CSF1-R TARGETED MOLECULAR MRI AGENTS FOR NON-INVASIVE IMAGING OF NEURO- AND PERIPHERAL INFLAMMATION

GENEVA, Aug. 7 -- FLAVOCURE BIOTECH, INC. filed a patent application (US2026/013558) for “CSF1-R TARGETED MOLECULAR MRI AGENTS FOR NON-INVASIVE IMAGING OF NEURO- AND PERIPHERAL INFLAMMATION”. With publication no. WO/2026/165511, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 49/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....